Form 4: Klaviyo CFO Amanda Whalen Executes Pre-Arranged Stock Sales and Conversions
Insider Transaction Report
Klaviyo's Chief Financial Officer, Amanda Whalen, converted Series B shares to Series A and subsequently sold a portion of her Series A common stock holdings totaling 15,000 shares for approximately $474,832 under a pre-arranged 10b5-1 trading plan.
Summary
- Chief Financial Officer Amanda Whalen converted 15,000 shares of Series B Common Stock into Series A Common Stock.
- Following the conversion, 15,000 shares of Series A Common Stock were sold.
- The sales included 14,800 shares at a weighted average price of $31.66 per share and 200 shares at $31.32 per share.
- Total proceeds from these sales amounted to approximately $474,832.
- All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.
- After these transactions, Amanda Whalen beneficially owns 517,831 shares of Series A Common Stock, which includes 34,799 direct shares and 483,032 unvested restricted stock units (RSUs).
- Additionally, she beneficially owns 449,193 shares of Series B Common Stock, comprising 189,818 direct shares and 259,375 unvested RSUs.
Sentiment
Score: 5
Explanation: Neutral. The filing reports a routine insider transaction under a pre-arranged 10b5-1 plan, which is a common and expected event for executives managing their equity. It does not convey positive or negative operational news or suggest a change in company fundamentals.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a discretionary sale based on new, non-public information.
Negatives
- A sale of 15,000 shares by a key executive, even if pre-planned, could be perceived negatively by some investors as it represents a reduction in direct equity exposure.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports past insider transactions.
Industry Context
This Form 4 filing reports a routine insider transaction under a pre-arranged trading plan. Such filings are common across all industries for executives managing their personal equity holdings and do not typically reflect specific industry trends or competitive dynamics.
Comparison to Industry Standards
- Form 4 filings are standard regulatory disclosures for insider transactions in the U.S. market.
- The reported transactions, being executed under a Rule 10b5-1 plan, align with common practices for executives to manage their stock holdings in a compliant and pre-scheduled manner, mitigating concerns of trading on material non-public information.
- No specific comparable companies, projects, or results are relevant for this type of routine insider transaction report, as it pertains to an individual's personal financial planning rather than company operational performance.
Stakeholder Impact
- Shareholders: May observe a planned sale by a key executive, which is a common occurrence under 10b5-1 plans and typically does not signal a change in company fundamentals or future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date the Reporting Person adopted the Rule 10b5-1 trading plan. |
| 07/11/2025 | Date of reported stock transactions (conversion and sales). |
| 07/14/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
Recommendation
holdKeywords
Klaviyo, KVYO, Insider Trading, Form 4, Stock Sale, CFO, Amanda Whalen, 10b5-1 Plan, Equity Conversion, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.